Exelixis, Inc. (NASDAQ:EXEL) is among the Renaissance Technologies Portfolio: 10 Biggest Stocks. On September 17, Morgan Stanley raised the stock’s price target to $50 from$46, while maintaining an Overweight rating for its shares. Morgan Stanley Maintains Overweight Rating For Exelixis, Inc. (EXEL), Price Target Raised To $50 Stock market data showing an upward trajectory. Photo by Burak The Weekender on Pexels In a research note to investors, the analyst noted that Zanzalintinib presents a significan ...